Amprenavir is a protease inhibitor used to treat HIV infection. It was approved by
the Food and Drug Administration on April 15, 1999, for twice-a-day dosing ...
Amprenavir (Agenerase - discontinued brand) is a drug prescribed to treat
infections with HIV. Side effects, drug interactions, and pregnancy safety
information is ...
Pharmacodynamics, Amprenavir is a protease inhibitor with activity against
Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part
Learn about Agenerase Capsules (Amprenavir Capsules) may treat, uses,
dosage, side effects, drug interactions, warnings, patient labeling, reviews, and ...
Easy to read patient leaflet for amprenavir. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Amprenavir is an antiviral medication in a group of HIV medicines called
protease (PRO-tee-ayz) inhibitors. Amprenavir prevents human
immunodeficiency virus ...
Amprenavir is an antiretroviral protease inhibitor used in the therapy and
prevention of human immunodeficiency virus (HIV) infection and the acquired ...
Jan 25, 2001 ... Approval. Amprenavir was approved by the U.S. Food and Drug Administration (
FDA) in 1999 for use in adults and children with HIV infection.
Manufacture of amprenavir was discontinued in October 2007. It is being
replaced by fosamprenavir (see fact sheet 448). Fosamprenavir is a pro-drug of ...
Query being created in qry_DrugSearch: qry_SearchResults_Search -
Recordcount: 3. Drugs at FDA: FDA Approved Drug Products. Links to Initial
Search Page ...